SY0916
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SY0916 has been proven to be a potent treatment agent against rheumatoid arthritis in preclinical studies and has been shown to…
SY0916 is a new platelet-activating factor receptor antagonist developed by our institute. In this study, the inhibitory effect…
SY0916 is a novel platelet-activating factor receptor antagonist. The objective of this study is to explore the anti-angiogenesis…
OBJECTIVE To investigate the in vitro anti-angiogenesis effect of platelet activating factor(PAF)receptor antagonist SY0916 on…
AbstractAim:To study the effects and mechanism of aromatic aminoketone (SY0916) on bone destruction in vitro.Methods:MC3T3-E1…